Ghiringhelli F - Search Results

1

Downregulation of Elovl5 promotes breast cancer metastasis through a lipid-droplet accumulation-mediated induction of TGF-β receptors.

Kieu TL, Pierre L, Derangère V, Perrey S, Truntzer C, Jalil A, Causse S, Groetz E, Dumont A, Guyard L, Arnould L, de Barros JP, Apetoh L, Rébé C, Limagne E, Jourdan T, Demizieux L, Masson D, Thomas C, Ghiringhelli F, Rialland M. Kieu TL, et al. Among authors: ghiringhelli f. Cell Death Dis. 2022 Sep 2;13(9):758. doi: 10.1038/s41419-022-05209-6. Cell Death Dis. 2022. PMID: 36056008 Free PMC article.

2

Links between innate and cognate tumor immunity.

Ghiringhelli F, Apetoh L, Housseau F, Kroemer G, Zitvogel L. Ghiringhelli F, et al. Curr Opin Immunol. 2007 Apr;19(2):224-31. doi: 10.1016/j.coi.2007.02.003. Epub 2007 Feb 15. Curr Opin Immunol. 2007. PMID: 17303400 Review.

3

[Calreticulin dictates the immunogenicity of anti-cancer chemotherapy and radiotherapy].

Apetoh L, Ghiringhelli F, Zitvogel L. Apetoh L, et al. Among authors: ghiringhelli f. Med Sci (Paris). 2007 Mar;23(3):257-8. doi: 10.1051/medsci/2007233257. Med Sci (Paris). 2007. PMID: 17349284 Free article. French. No abstract available.

4

Immunogenic chemotherapy: discovery of a critical protein through proteomic analyses of tumor cells.

Apetoh L, Obeid M, Tesniere A, Ghiringhelli F, Fimia GM, Piacentini M, Kroemer G, Zitvogel L. Apetoh L, et al. Among authors: ghiringhelli f. Cancer Genomics Proteomics. 2007 Mar-Apr;4(2):65-70. Cancer Genomics Proteomics. 2007. PMID: 17804868 Free article. Review.

5

Molecular determinants of immunogenic cell death: surface exposure of calreticulin makes the difference.

Chaput N, De Botton S, Obeid M, Apetoh L, Ghiringhelli F, Panaretakis T, Flament C, Zitvogel L, Kroemer G. Chaput N, et al. Among authors: ghiringhelli f. J Mol Med (Berl). 2007 Oct;85(10):1069-76. doi: 10.1007/s00109-007-0214-1. Epub 2007 May 22. J Mol Med (Berl). 2007. PMID: 17891368 Review.

6

Molecular characteristics of immunogenic cancer cell death.

Tesniere A, Panaretakis T, Kepp O, Apetoh L, Ghiringhelli F, Zitvogel L, Kroemer G. Tesniere A, et al. Among authors: ghiringhelli f. Cell Death Differ. 2008 Jan;15(1):3-12. doi: 10.1038/sj.cdd.4402269. Epub 2007 Nov 16. Cell Death Differ. 2008. PMID: 18007663 Review.

7

Immunological aspects of cancer chemotherapy.

Zitvogel L, Apetoh L, Ghiringhelli F, Kroemer G. Zitvogel L, et al. Among authors: ghiringhelli f. Nat Rev Immunol. 2008 Jan;8(1):59-73. doi: 10.1038/nri2216. Nat Rev Immunol. 2008. PMID: 18097448 Review.

8

Cancer chemotherapy: not only a direct cytotoxic effect, but also an adjuvant for antitumor immunity.

Ménard C, Martin F, Apetoh L, Bouyer F, Ghiringhelli F. Ménard C, et al. Among authors: ghiringhelli f. Cancer Immunol Immunother. 2008 Nov;57(11):1579-87. doi: 10.1007/s00262-008-0505-6. Epub 2008 Mar 28. Cancer Immunol Immunother. 2008. PMID: 18369619 Free PMC article. Review.

9

Pathologic complete response to neoadjuvant chemotherapy of breast carcinoma is associated with the disappearance of tumor-infiltrating foxp3+ regulatory T cells.

Ladoire S, Arnould L, Apetoh L, Coudert B, Martin F, Chauffert B, Fumoleau P, Ghiringhelli F. Ladoire S, et al. Among authors: ghiringhelli f. Clin Cancer Res. 2008 Apr 15;14(8):2413-20. doi: 10.1158/1078-0432.CCR-07-4491. Clin Cancer Res. 2008. PMID: 18413832

10

Molecular interactions between dying tumor cells and the innate immune system determine the efficacy of conventional anticancer therapies.

Apetoh L, Tesniere A, Ghiringhelli F, Kroemer G, Zitvogel L. Apetoh L, et al. Among authors: ghiringhelli f. Cancer Res. 2008 Jun 1;68(11):4026-30. doi: 10.1158/0008-5472.CAN-08-0427. Cancer Res. 2008. PMID: 18519658 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

472 results

Search Page